Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
75.31
-2.27 (-2.93%)
Oct 14, 2026, 1:08 PM EDT - Market open
Dianthus Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $158 | Buy | Reiterates | $158 | +109.80% | Oct 1, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $125 | Buy | Maintains | $125 | +65.98% | Sep 29, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 24, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 18, 2026 |
| Citi | Citi | Buy Initiates $156 | Buy | Initiates | $156 | +107.14% | Sep 4, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $133 | Buy | Maintains | $133 | +76.60% | Aug 13, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $134 | Buy | Maintains | $134 | +77.93% | Aug 10, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $110 → $128 | Buy | Maintains | $110 → $128 | +69.96% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.